Jin-Seu Park

Title: Innovations by Jin-Seu Park in Protein Transduction

Introduction

Jin-Seu Park is a notable inventor based in Chuncheon-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of protein transduction domains. His work focuses on enhancing the efficiency of fusion compounds that can be utilized in pharmaceutical compositions.

Latest Patents

Jin-Seu Park holds a patent for a "Protein transduction domain, fusion compound containing the same, and pharmaceutical composition containing the fusion compound." This invention proposes a more efficient protein transduction domain and fusion compound. Through extensive testing of various candidate peptides, Park and his team discovered that a GK1 peptide, consisting of 18 amino acids, can bond with high-molecular-weight materials such as proteins. This bonding allows these materials to penetrate living bodies, including cells, tissues, or blood, effectively. The fusion compound, oligonucleotide, or vector derived from this research can be applied as a pharmaceutical composition for preventing or treating diseases.

Career Highlights

Jin-Seu Park has established himself as a key figure in his field through his innovative research and patent contributions. His work has the potential to impact various medical applications, particularly in drug delivery systems.

Collaborations

Park has collaborated with notable colleagues, including Soo-Young Choi and Kyuhyung Han, who have contributed to his research endeavors.

Conclusion

Jin-Seu Park's innovative work in protein transduction domains represents a significant advancement in biotechnology. His contributions have the potential to enhance pharmaceutical applications and improve treatment methods for various diseases.